SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
Go back to SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types| (NASDAQ: SKIN) | Delayed: 0.74 +0.05 (7.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $ | |||
| Open | $0.69 | 52 Week Low | $ | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.68 | EPS | $ | |||
| Volume | 417,242 | |||||
| (NASDAQ: SKIN) | Delayed: 0.74 +0.05 (7.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $ | |||
| Open | $0.69 | 52 Week Low | $ | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.68 | EPS | $ | |||
| Volume | 417,242 | |||||
